Li Wei, Gu Hongqiu, Teo Koon K, Bo Jian, Wang Yang, Yang Jingang, Wang Xingyu, Zhang Hongye, Sun Yi, Jia Xuan, He Xinye, Zhao Xiuwen, Cheng Xiaoru, Li Jian, Rangarajan Sumathy, Chen Chunming, Yusuf Salim, Liu Lisheng
aState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China bPopulation Health Research Institute, McMaster University-Hamilton Health Sciences, Hamilton, Ontario, Canada cLaboratory of Human Genetics dBeijing Hypertension League Institute eCenter of Disease Control & Prevention, Beijing, China.
J Hypertens. 2016 Jan;34(1):39-46. doi: 10.1097/HJH.0000000000000745.
Identification and treatment of hypertension in China remain suboptimal despite high prevalence of hypertension and increasing incidence of stroke and myocardial infarction.
This study reported blood pressure levels, prevalence, awareness, treatment, and control rates of hypertension, in addition to drug treatments in China.
This is a country-specific analysis of 45 108 individuals, average age 51.4 (standard deviation 9.6) (35-70) years, enrolled between 2005 and 2009, from 70 rural and 45 urban communities in 12 provinces.
Among 18 915 (41.9% overall population) hypertensive participants, 7866 (41.6%) were aware, 6503 (34.4%) treated but only 1545 (8.2%) controlled. Prevalence of hypertension was higher, but awareness, treatment, and control were lower in rural than urban residents. Prevalence of hypertension was highest in eastern (44.3%), intermediate in central (39.3%), and lowest in western regions (37.0%). Awareness was higher in central (44.3%) and eastern (42.4%) but lower in western regions (37.0%). Similar patterns were observed in treatment rates, 37.7% central, 35.2% eastern, and 26.7% in western regions with control rates of 8.3% in eastern, 7.6% central, and 5.3% west regions. Of 4744 participants receiving documented treatments, 37.5% received traditional combination drugs alone, 55.4% western drugs alone and 7.1% combination of traditional combination drug in addition to western drugs.
In China, hypertension is common, and while recent studies suggest some improvements, more than half of affected individuals were unaware that they had hypertension. Rates of control remain low. National programs effective in preventing and controlling hypertension in China are urgently needed.
尽管中国高血压患病率高，且中风和心肌梗死发病率不断上升，但高血压的识别与治疗情况仍不尽人意。
本研究报告了中国高血压的血压水平、患病率、知晓率、治疗率和控制率，以及药物治疗情况。
这是一项针对特定国家的分析，研究对象为2005年至2009年间招募的45108名个体，平均年龄51.4岁（标准差9.6）（35 - 70岁），来自12个省份的70个农村社区和45个城市社区。
在18915名（占总人口41.9%）高血压参与者中，7866名（41.6%）知晓自己患病，6503名（34.4%）接受了治疗，但只有1545名（8.2%）得到控制。农村居民高血压患病率高于城市居民，但知晓率、治疗率和控制率低于城市居民。高血压患病率在东部最高（44.3%），中部次之（39.3%），西部最低（37.0%）。知晓率中部（44.3%）和东部（42.4%）较高，西部较低（37.0%）。治疗率也呈现类似模式，中部为37.7%，东部为35.2%，西部为26.7%，控制率东部为8.3%，中部为7.6%，西部为5.3%。在4744名接受记录治疗的参与者中，37.5%仅接受传统复方药物治疗，55.4%仅接受西药治疗，7.1%同时接受传统复方药物和西药治疗。
在中国，高血压很常见，尽管近期研究显示有一定改善，但仍有超过一半的患者不知道自己患有高血压。控制率仍然很低。迫切需要在中国实施有效的全国性高血压防控项目。
